DESFLURANE SANDOZ (Sandoz Pty Ltd)
Product name
DESFLURANE SANDOZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
134 working days (255)
Active ingredients
desflurane
Registration type
New generic medicine
Indication
DESFLURANE SANDOZ (solution for inhalation) is indicated as an inhalation agent for maintenance of anaesthesia. DESFLURANE SANDOZ is not recommended for mask induction of anaesthesia because of a high incidence of moderate to severe upper airway adverse events.